RNA-seq of human cell lines to investigate epigenetic regulatory pathways in leukaemia

ABSTRACT: 3 acute myeloid leukaemic cell lines and 1 control non-small cell lung cancer cell line were treated for 24h with 2 different doses of the KAT2A inhibitor 3-butyrolactone or DMSO vehicle.

ORGANISM(S): Homo sapiens

SUBMITTER: The Wellcome Trust Sanger Institute 

PROVIDER: S-ECPF-ERAD-213 | biostudies-other |

REPOSITORIES: biostudies-other